nach oben

HNO

Erschienen in:

12.11.2019 | Larynxkarzinom | CME Zertifizierte Fortbildung

Die Laryngektomie – noch zeitgemäß?

verfasst von: J. M. Vahl, P. J. Schuler, J. Greve, S. Laban, A. Knopf, Univ.-Prof. Dr. T. K. Hoffmann

Erschienen in: HNO | Ausgabe 12/2019

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die Kehlkopfentfernung (Laryngektomie) bietet für Patienten mit fortgeschrittenen Larynx- und Hypopharynxkarzinomen ohne Fernmetastasen einen kurativen Ansatz. Insbesondere bei Vorliegen eines cT4a-Karzinoms ist die Laryngektomie der primären Radio(chemo)therapie prognostisch (retrospektiv) überlegen. Weitere wichtige Indikationen für eine Laryngektomie stellen eine tumorbedingte Larynxdysfunktion wie Schluckunfähigkeit bzw. Aspirationsneigung und ein Rezidiv nach vorausgegangener Radio(chemo)therapie dar. Das operative Verfahren ist hoch standardisiert und ausreichend sicher. Der mit einer Laryngektomie einhergehende Stimmverlust ist durch eine funktionelle Rehabilitation (Ruktus, Stimmprothese) zu kompensieren. Die vorliegende Arbeit verschafft einen Überblick hinsichtlich Indikation, präoperativer Diagnostik, operativem Verfahren, möglichen Komplikationen, alternativer Behandlungsansätze sowie Rehabilitation und Prognose. Die Laryngektomie gehört auch weiterhin zum bewährten Standardrepertoire der modernen Kopf-Hals-Onkologie.

Kramp B, Dommerich S (2009) Kanülen und Stimmprothesen. Laryngorhinootologie 88:S95–S118PubMed

Pantel M, Guntinas-Lichius O (2012) Larynxkarzinom: Epidemiologie, Risikofaktoren und Überleben (Leitthema). HNO 60:32–40PubMed

Wiegand S (2016) Evidenz und Evidenzlücken zur Chirurgie des Larynxkarzinoms. Laryngorhinootologie 95:S192–S216PubMed

Talamini R, Bosetti C, La Vecchia C et al (2002) Combined effect of tobacco and alcohol on laryngeal cancer risk: a case—control study. Cancer Causes Control 13:957–964PubMed

Michel O (2016) Berufskrankheit: Kehlkopfkarzinom. HNO 64:268–270PubMed

Castellsagué X, Alemany L, Quer M et al (2016) HPV involvement in head and neck cancers: comprehensive assessment of biomarkers in 3680 patients. JNCI J Natl Cancer Inst 108(6):djv403. https://doi.org/10.1093/jnci/djv403 CrossRefPubMed

Davidson SM, Ko HC, Harari PM et al (2018) Impact of HPV status on the prognostic potential of the AJCC staging system for larynx cancer. Otolaryngol Head Neck Surg 159:456–465PubMedPubMedCentral

Bootz F, Singer S, Habermann C et al (2019) Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF): Diagnostik, Therapie und Nachsorge des Larynxkarzinoms. http://www.leitlinienprogramm-onkologie.de/leitlinien/larynxkarzinom/. Zugegriffen: 27. Apr. 2019 (Langversion 1.0,2019, AWMF-Registernummer: 017/076OL)

Güneş S, Başaran B, Aslan İ et al (2018) Surgical treatment of hypopharyngeal cancer. Turkish J Ear Nose Throat 28:105–111

10.

Petersen JF, Timmermans AJ, Van Dijk BA et al (2018) Trends in treatment, incidence and survival of hypopharynx cancer: a 20-year population-based study in the Netherlands. Eur Arch Otorhinolaryngol 275:181–189PubMed

11.

Huang C‑C, Hsiao J‑R, Lee W‑T et al (2017) Investigating the association between alcohol and risk of head and neck cancer in Taiwan. Sci Rep 7:9701. https://doi.org/10.1038/s41598-017-08802-4 CrossRefPubMedPubMedCentral

12.

Menvielle G, Luce D, Goldberg P et al (2004) Smoking, alcohol drinking and cancer risk for various sites of the larynx and hypopharynx. A case—control study in France. Eur J Cancer Prev 13:165–172PubMed

13.

Löhler J, Gerstner A, Bootz F et al (2014) Incidence and localization of abnormal mucosa findings in patients consulting ENT outpatient clinics and data analysis of a cancer registry. Eur Arch Otorhinolaryngol 271:1289–1297PubMed

14.

Poon C, Stenson K (2019) Overview of the diagnosis and staging of head and neck cancer. UpToDate. https://www.uptodate.com/contents/overview-of-the-diagnosis-and-staging-of-head-and-neck-cancer

15.

Kaanders J, Werner J, Wendt T et al (2006) Larynxkarzinom. In: Schmoll H‑J, Höffken K, Possinger K (Hrsg) Kompendium Internistische Onkologie. Springer, Berlin, Heidelberg, S 3397–3420

16.

Werner JA (2017) Totale Laryngektomie. In: Rettinger G, Hosemann WG, Hüttenbrink K‑B, Werner JA (Hrsg) HNO-Operationslehre. Thieme, Stuttgart

17.

Agrawal N, Goldenberg D (2008) Primary and salvage total laryngectomy. Otolaryngol Clin North Am 41:771–780PubMed

18.

Steuer CE, El-Deiry M, Parks JR et al (2017) An update on larynx cancer. CA Cancer J Clin 67:31–50PubMed

19.

Kostev K, Jacob LE, Kalder M et al (2018) Association of laryngeal cancer with vocal cord leukoplakia and associated risk factors in 1,184 patients diagnosed in otorhinolaryngology practices in Germany. mol clin onc 8:689–693

20.

National Comprehensive Cancer Network (2018) NCCN Clinical Practice Guidelines in Oncology (NCCN® guidelines): head and neck cancers. National Comprehensive Cancer Network, Fort Washington (Version 2.2018)

21.

Haerle SK, Schmid D, Ahmad N et al (2011) The value of 18F-FDG PET/CT for the detection of distant metastases in high-risk patients with head and neck squamous cell carcinoma. Oral Oncol 47:653–659PubMed

22.

Mehanna H, Mcconkey CC, Rahman JK et al (2017) PET-NECK. Health Technol Assess 21(17):1–122. https://doi.org/10.3310/hta21170 (A multicentre randomised Phase III non-inferiority trial comparing a positron emission tomography—computerised tomography-guided watch-and-wait policy with planned neck dissection in the management of locally advanced (N2/N3) nodal metastases in patients with squamous cell head and neck cancer)CrossRefPubMedPubMedCentral

23.

Mehanna H, Wong W‑L, Mcconkey CC et al (2016) PET-CT surveillance versus neck dissection in advanced head and neck cancer. N Engl J Med 374:1444–1454PubMed

24.

Grosse J, Hellwig D (2018) Update: PET/CT und PET/MRT bei Tumoren des Kopf-Hals-Bereiches. Nuklearmediziner 41:222–231

25.

Thompson C, John MS, Lawson G et al (2013) Diagnostic value of sentinel lymph node biopsy in head and neck cancer: a meta-analysis. Eur Arch Otorhinolaryngol 270:2115–2122PubMed

26.

Tomifuji M, Shiotani A, Fujii H et al (2008) Sentinel node concept in clinically n0 laryngeal and hypopharyngeal cancer. Ann Surg Oncol 15:2568PubMed

27.

Werner J, Dünne A, Ramaswamy A et al (2002) Sentinel node detection in N0 cancer of the pharynx and larynx. Br J Cancer 87:711PubMedPubMedCentral

28.

Chen PG, Schoeff SS, Watts CA et al (2014) Utility of abdominal imaging to assess for liver metastasis in patients with head and neck cancer and abnormal liver function tests. Am J Otolaryngol 35:137–140PubMed

29.

Vahl J, Hoffmann T (2019) Neck dissection-Surgical treatment of cervical lymphatic drainage pathways. HNO 67(1):61–76. https://doi.org/10.1007/s00106-018-0601-7 CrossRefPubMed

30.

Alicandri-Ciufelli M, Bonali M, Piccinini A et al (2013) Surgical margins in head and neck squamous cell carcinoma: what is ‘close’? Eur Arch Otorhinolaryngol 270:2603–2609PubMed

31.

Schlag PM, Hartmann JT, Budach V (2011) Weichgewebetumoren. Springer, Berlin, Heidelberg

32.

Bonkowsky V, Strutz J (2017) Laryngektomie. In: Strutz J, Mann WJ (Hrsg) Praxis der HNO-Heilkunde, Kopf- und Halschirurgie. Thieme, Stuttgart

33.

Fagan J (2016) Total laryngectomy. In: Open access atlas of otolaryngology, head & neck operative surgery https://doi.org/10.15641/0-7992-2534-1 CrossRef

34.

Schuler PJ (2018) Robotische Chirurgie – operiert der Roboter? Laryngorhinootologie 97:S231–S278PubMedPubMedCentral

35.

Schuler PJ, Hoffmann TK, Veit JA et al (2017) Hybrid procedure for total laryngectomy with a flexible robot-assisted surgical system. Int J Med Robotics Comput Assist Surg 13:e1749

36.

Krishnan G, Krishnan S (2017) Transoral robotic surgery total laryngectomy: evaluation of functional and survival outcomes in a retrospective case series at a single institution. ORL 79:191–201PubMed

37.

Lawson G, Mendelsohn AH, Van der Vorst S et al (2013) Transoral robotic surgery total laryngectomy. Laryngoscope 123:193–196PubMed

38.

Smith RV, Schiff BA, Sarta C et al (2013) Transoral robotic total laryngectomy. Laryngoscope 123:678–682PubMed

39.

Sheng X, Zhang S, Song X et al (2013) Meta-analysis on the risk factors for stomal recurrence after total laryngectomy. Lin Chuang Erh Pi Yen Hou Ko Tsa Chih

40.

Teutsch S, Bas M, Bier H et al (2017) Stomarezidive, eine klinisch-pathologische Betrachtung. Laryngorhinootologie 96:239–243PubMed

41.

Manfro G, Dias FL, De Farias TP (2018) Tracheostomy complications. In: De Farias TP (Hrsg) Tracheostomy – A surgical guide. Springer, Berlin, Heidelberg, S 307–319

42.

Laccourreye O, Hans S, Borzog-Grayeli A et al (2000) Complications of postoperative radiation therapy after partial laryngectomy in supraglottic cancer: a long-term evaluation. Otolaryngol Head Neck Surg 122:752–757PubMed

43.

Lee JH, Machtay M, Unger LD et al (1998) Prophylactic gastrostomy tubes in patients undergoing intensive irradiation for cancer of the head and neck. Arch Otolaryngol Head Neck Surg 124:871–875PubMed

44.

Chung EJ, Kim GW, Cho BK et al (2016) Pattern of lymph node metastasis in hypopharyngeal squamous cell carcinoma and indications for level VI lymph node dissection. Head Neck 38:E1969–E1973PubMed

45.

Pfister DG, Laurie SA, Weinstein GS et al (2006) American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer. JCO 24:3693–3704

46.

Robbins KT, Clayman G, Levine PA et al (2002) Neck dissection classification update: revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology—Head and Neck Surgery. Arch Otolaryngol Head Neck Surg 128:751–758PubMed

47.

Forastiere AA, Zhang Q, Weber RS et al (2013) Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer. JCO 31:845

48.

Langendijk JA, Ferlito A, Takes RP et al (2010) Postoperative strategies after primary surgery for squamous cell carcinoma of the head and neck. Oral Oncol 46:577–585PubMed

49.

Le Tourneau C, Jung G‑M, Borel C et al (2008) Prognostic factors of survival in head and neck cancer patients treated with surgery and postoperative radiation therapy. Acta Otolaryngol 128:706–712PubMed

50.

Bernier J, Cooper JS (2005) Chemoradiation after surgery for high-risk head and neck cancer patients: how strong is the evidence? Oncologist 10:215–224PubMed

51.

Group* DOVaLCS (1991) Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324:1685–1690

52.

Blanchard P, Baujat B, Holostenco V et al (2011) Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): a comprehensive analysis by tumour site. Radiother Oncol 100:33–40PubMed

53.

Weber RS, Berkey BA, Forastiere A et al (2003) Outcome of salvage total laryngectomy following organ preservation therapy: the Radiation Therapy Oncology Group trial 91-11. Arch Otolaryngol Head Neck Surg 129:44–49PubMed

54.

Budach V, Cho C‑H, Sedlmaier B et al (2012) Five years’ results of the German ARO 04-01 trial of concurrent 72 Gy hyperfractionated accelerated radiation therapy (HART) plus once weekly cisplatinum/5-FU versus mitomycin C/5-FU in stage IV head and neck cancer. J Clin Oncol 30:5512

55.

Budach V, Stromberger C, Poettgen C et al (2015) Hyperfractionated accelerated radiation therapy (HART) of 70.6 Gy with concurrent 5‑FU/Mitomycin C is superior to HART of 77.6 Gy alone in locally advanced head and neck cancer: long-term results of the ARO 95-06 randomized phase III trial. Int J Radiat Oncol Biol Phys 91:916–924PubMed

56.

Bauml JM, Vinnakota R, Anna Park YH et al (2019) Cisplatin versus cetuximab with definitive concurrent radiotherapy for head and neck squamous cell carcinoma: An analysis of veterans health affairs data. Cancer 125:406–415PubMed

57.

Gillison ML, Trotti AM, Harris J et al (2019) Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial. Lancet 393:40–50PubMed

58.

Xiang M, Holsinger FC, Colevas AD et al (2018) Survival of patients with head and neck cancer treated with definitive radiotherapy and concurrent cisplatin or concurrent cetuximab: A Surveillance, Epidemiology, and End Results-Medicare analysis. Cancer 124:4486–4494PubMed

59.

Ferris RL, Blumenschein G Jr, Fayette J et al (2016) Nivolumab for recurrent squamous-cell carcinoma of the head and neck. N Engl J Med 375:1856–1867PubMedPubMedCentral

60.

Vermorken JB, Mesia R, Rivera F et al (2008) Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med 359:1116–1127PubMed

61.

Nuyts S, Lambrecht M, Duprez F et al (2013) Reduction of the dose to the elective neck in head and neck squamous cell carcinoma, a randomized clinical trial using intensity modulated radiotherapy (IMRT). Dosimetrical analysis and effect on acute toxicity. Radiother Oncol 109:323–329PubMed

62.

Garden AS, Harris J, Trotti A et al (2008) Long-term results of concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: a phase II trial of the radiation therapy oncology group (RTOG 99-14). Int J Radiat Oncol Biol Phys 71:1351–1355PubMedPubMedCentral

63.

Machtay M, Moughan J, Trotti A et al (2008) Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. JCO 26:3582

64.

Haddad R, O’neill A, Rabinowits G et al (2013) Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial. Lancet Oncol 14:257–264PubMed

65.

Worden FP, Moyer J, Lee JS et al (2009) Chemoselection as a strategy for organ preservation in patients with T4 laryngeal squamous cell carcinoma with cartilage invasion. Laryngoscope 119:1510–1517PubMedPubMedCentral

66.

Budach W, Bölke E, Kammers K et al (2016) Induction chemotherapy followed by concurrent radio-chemotherapy versus concurrent radio-chemotherapy alone as treatment of locally advanced squamous cell carcinoma of the head and neck (HNSCC): A meta-analysis of randomized trials. Radiother Oncol 118:238–243PubMed

67.

Dietz A, Wichmann G, Kuhnt T et al (2018) Induction chemotherapy (IC) followed by radiotherapy (RT) versus cetuximab plus IC and RT in advanced laryngeal/hypopharyngeal cancer resectable only by total laryngectomy—final results of the larynx organ preservation trial DeLOS-II. Ann Oncol 29:2105–2114PubMed

68.

Lefebvre JL, Ang KK, Panel LPC (2009) Larynx preservation clinical trial design: key issues and recommendations—a consensus panel summary. Head Neck 31:429–441PubMed

69.

Dziegielewski PT, O’connell DA, Klein M et al (2012) Primary total laryngectomy versus organ preservation for T3/T4a laryngeal cancer: a population-based analysis of survival. J Otolaryngol Head Neck Surg 41(Suppl 1):S56–S64PubMed

70.

Timme DW, Jonnalagadda S, Patel R et al (2015) Treatment selection for T3/T4a laryngeal cancer: chemoradiation versus primary surgery. Ann Otol Rhinol Laryngol 124:845–851PubMed

71.

Sanabria A, Chaves AL, Kowalski LP et al (2017) Organ preservation with chemoradiation in advanced laryngeal cancer: the problem of generalizing results from randomized controlled trials. Auris Nasus Larynx 44:18–25PubMed

72.

Grover S, Swisher-Mcclure S, Mitra N et al (2015) Total laryngectomy versus larynx preservation for T4a larynx cancer: patterns of care and survival outcomes. Int J Radiat Oncol Biol Phys 92:594–601PubMed

73.

Eschmann S‑M, Paulsen F, Reimold M et al (2005) Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy. J Nucl Med 46:253–260PubMed

74.

Mortensen LS, Johansen J, Kallehauge J et al (2012) FAZA PET/CT hypoxia imaging in patients with squamous cell carcinoma of the head and neck treated with radiotherapy: results from the DAHANCA 24 trial. Radiother Oncol 105:14–20PubMed

75.

Hoffmann TK (2012) Systemic therapy strategies for head-neck carcinomas: Current status. GMS Curr Top Otorhinolaryngol Head Neck Surg. https://doi.org/10.3205/cto000085 CrossRefPubMedPubMedCentral

76.

Silverman DA, Puram SV, Rocco JW et al (2019) Salvage laryngectomy following organ-preservation therapy—An evidence-based review. Oral Oncol 88:137–144PubMed

77.

Birkeland AC, Rosko AJ, Issa MR et al (2016) Occult nodal disease prevalence and distribution in recurrent laryngeal cancer requiring salvage laryngectomy. Otolaryngol Head Neck Surg 154:473–479PubMedPubMedCentral

78.

Hussain T, Kanaan O, Höing B et al (2018) Die Rolle der elektiven Neck dissection bei Salvage Laryngektomie – eine retrospektive Analyse. Laryngorhinootologie 97:694–701PubMed

79.

Rosko A, Birkeland A, Shuman A et al (2017) Positron emission tomography—CT prediction of occult nodal metastasis in recurrent laryngeal cancer. Head Neck 39:980–987PubMedPubMedCentral

80.

Al-Mamgani A, Tans L, Van Rooij P et al (2012) A single-institutional experience of 15 years of treating T3 laryngeal cancer with primary radiotherapy, with or without chemotherapy. Int J Radiat Oncol Biol Phys 83:1000–1006PubMed

81.

Rothmeier N, Hoffmann T, Lehnerdt G et al (2013) Chirurgisches Management der persistierenden Speichelfistel nach Salvage-Laryngektomie. Laryngorhinootologie 92:236–243PubMed

82.

Goepfert RP, Hutcheson KA, Lewin JS et al (2017) Complications, hospital length of stay, and readmission after total laryngectomy. Cancer 123:1760–1767PubMed

83.

Karsten RT, Timmermans AJ, Ten Cate J et al (2018) Direct complications and routine ICU admission after total laryngectomy. Acta Otolaryngol 138(12):1128–1135. https://doi.org/10.1080/00016489.2018.1515497 CrossRefPubMed

84.

Helman SN, Brant JA, Kadakia SK et al (2018) Factors associated with complications in total laryngectomy without microvascular reconstruction. Head Neck 40:2409–2415PubMed

85.

Hasan Z, Dwivedi R, Gunaratne D et al (2017) Systematic review and meta-analysis of the complications of salvage total laryngectomy. Eur J Surg Oncol 43:42–51PubMed

86.

Hall FT, O’brien CJ, Clifford AR et al (2003) Clinical outcome following total laryngectomy for cancer. ANZ J Surg 73:300–305PubMed

87.

Furuta Y, Homma A, Oridate N et al (2008) Surgical complications of salvage total laryngectomy following concurrent chemoradiotherapy. Int J Clin Oncol 13:521–527PubMed

88.

Upile T, Triaridis S, Kirkland P et al (2005) The management of carotid artery rupture. Eur Arch Otorhinolaryngol 262:555–560PubMed

89.

Grau C, Johansen LV, Hansen HS et al (2003) Salvage laryngectomy and pharyngocutaneous fistulae after primary radiotherapy for head and neck cancer: a national survey from DAHANCA. Head Neck 25:711–716PubMed

90.

Stankovic M, Milisavljevic D, Zivic M et al (2015) Primary and salvage total laryngectomy. Influential factors, complications, and survival. J BUON 20:527–539PubMed

91.

Bratzler DW, Dellinger EP, Olsen KM et al (2013) Clinical practice guidelines for antimicrobial prophylaxis in surgery. Surg Infect 14:73–156

92.

Patel PN, Jayawardena AD, Walden RL et al (2018) Evidence-based use of perioperative antibiotics in otolaryngology. Otolaryngol Head Neck Surg 158:783–800PubMed

93.

Seidel DU (2018) Lebensqualität mit Stimmprothese nach totaler Laryngektomie. Laryngorhinootologie 97:829–832PubMed

94.

Dedivitis RA, Aires FT, Cernea CR et al (2015) Pharyngocutaneous fistula after total laryngectomy: systematic review of risk factors. Head Neck 37:1691–1697PubMed

95.

Formeister EJ, Alemi AS, El-Sayed I et al (2018) Shorter interval between radiation therapy and salvage laryngopharyngeal surgery increases complication rates following microvascular free tissue transfer. Am J Otolaryngol 39:548–552PubMed

96.

Miles BA (2018) Moving toward improved outcomes in salvage laryngectomy. Ann Surg Oncol 25:1110–1111PubMed

97.

Achim V, Bash J, Mowery A et al (2017) Prognostic indication of sarcopenia for wound complication after total laryngectomy. JAMA Otolaryngol Head Neck Surg 143:1159–1165PubMed

98.

Filimonov A, Brady JS, Govindan A et al (2017) Postoperative complications of total laryngectomy in diabetic patients. Laryngoscope 127:2247–2251PubMed

99.

Gourin CG, Stewart CM, Frick KD et al (2019) Association of hospital volume with laryngectomy outcomes in patients with larynx cancer. JAMA Otolaryngol Head Neck Surg 145:62–70PubMed

100.

Eadie TL, Bowker BC (2012) Coping and quality of life after total laryngectomy. Otolaryngol Head Neck Surg 146:959–965PubMedPubMedCentral

101.

Mallis A, Goumas P, Mastronikolis N et al (2011) Factors influencing quality of life after total laryngectomy: a study of 92 patients. Eur Rev Med Pharmacol Sci 15:937–942PubMed

102.

Minovi A, Nowak C, Marek A et al (2009) Lebensqualität bei Langzeitüberlebenden nach Laryngektomie. Laryngorhinootologie 88:18–22PubMed

103.

Hanna E, Sherman A, Cash D et al (2004) Quality of life for patients following total laryngectomy vs chemoradiation for laryngeal preservation. Arch Otolaryngol Head Neck Surg 130:875–879PubMed

104.

Trivedi NP, Swaminathan DK, Thankappan K et al (2008) Comparison of quality of life in advanced laryngeal cancer patients after concurrent chemoradiotherapy vs total laryngectomy. Otolaryngol Head Neck Surg 139:702–707PubMed

105.

Lotempio MM, Wang KH, Sadeghi A et al (2005) Comparison of quality of life outcomes in laryngeal cancer patients following chemoradiation vs. total laryngectomy. Otolaryngol Head Neck Surg 132:948–953PubMed

106.

Lenarz T, Boenninghaus H‑G (2012) MdE-Werte (GdB-Werte). In: Hals-Nasen-Ohren-Heilkunde. Springer, Berlin, Heidelberg, S 403–406

107.

Slesina W, Rennert D, Weber A (2014) Patientenbesuche im Krankenhaus durch Besuchsdienste von Krebs-Selbsthilfegruppen – zur Prozess- und Ergebnisqualität. Gesundheitswesen 76:847–855PubMed

108.

Lorenz KJ (2014) Stimmrehabilitation nach Laryngektomie. Laryngorhinootologie 93:44–66PubMed

109.

Doescher J, Scheckenbach K, Angerstein W et al (2016) Evaluation of customized prosthesis for irregularly formed Tracheostoma after laryngectomy. Ann Otol Rhinol Laryngol 125:145–150PubMed

110.

Hackenberg S, Kleinsasser N, Scherzad A et al (2018) Microvascular reconstruction of the larynx following total laryngectomy. Laryngorhinootologie 97:100–109PubMed

111.

Rosa VM, Fores JML, Da Silva EPF et al (2018) Interdisciplinary interventions in the perioperative rehabilitation of total laryngectomy: an integrative review. Clinics. https://doi.org/10.6061/clinics/2018/e484s CrossRefPubMedPubMedCentral

112.

Landis BN, Giger R, Lacroix J‑S et al (2003) Swimming, snorkeling, breathing, smelling, and motorcycling after total laryngectomy. Am J Med 114:341–342PubMed

Titel: Die Laryngektomie – noch zeitgemäß?
verfasst von: J. M. Vahl
P. J. Schuler
J. Greve
S. Laban
A. Knopf
Univ.-Prof. Dr. T. K. Hoffmann
Publikationsdatum: 12.11.2019
Verlag: Springer Medizin
Schlagwörter: Larynxkarzinom
Hypopharynxkarzinom
Hypopharynxkarzinom
Larynxkarzinom
Laryngektomie
Neck dissection
Erschienen in: HNO / Ausgabe 12/2019
Print ISSN: 0017-6192
Elektronische ISSN: 1433-0458
DOI: https://doi.org/10.1007/s00106-019-00769-0

Neu im Fachgebiet HNO

16.04.2024 | HNO-Chirurgie | Nachrichten

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Die Laryngektomie – noch zeitgemäß?

Zusammenfassung

Neu im Fachgebiet HNO

HNO-Op. auch mit über 90?

Intrakapsuläre Tonsillektomie gewinnt an Boden

Bilateraler Hörsturz hat eine schlechte Prognose

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Update HNO

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2019

Update zu HPV-assoziierten Kopf-Hals-Karzinomen – Highlights der ASCO-Jahrestagung 2019

Immuntherapie von Kopf-Hals-Tumoren

Onkologische Therapiekonzepte bei Kopf-Hals-Tumoren

Pharyngeale Säurebelastung bei unterschiedlichen Befunden der funktionellen Endoskopie

Neue Aspekte in der Behandlung von Schilddrüsenkarzinomen

Langsam progrediente Dysphonie

Neu im Fachgebiet HNO

HNO-Op. auch mit über 90?

Intrakapsuläre Tonsillektomie gewinnt an Boden

Bilateraler Hörsturz hat eine schlechte Prognose

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Update HNO